Literature DB >> 19602325

Antihypertensive drugs and central blood pressure.

Carmel M McEniery1.   

Abstract

Recent evidence suggests that central blood pressure is a more important determinant of cardiovascular risk than brachial pressure. Interestingly, antihypertensive drugs exert different effects on brachial and central pressure. Traditional beta-blockers, such as atenolol, appear to have an adverse impact on central pressure, despite lowering brachial pressure. This may help to explain the results of recent large outcome studies using atenolol. Further research is required to clarify whether other antihypertensive agents lower central pressure beyond the effects observed on brachial pressure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602325     DOI: 10.1007/s11906-009-0043-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

1.  Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment.

Authors:  P Boutouyrie; C Bussy; D Hayoz; J Hengstler; N Dartois; B Laloux; H Brunner; S Laurent
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

2.  Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  Y Nakayama; K Tsumura; N Yamashita; K Yoshimaru; T Hayashi
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

3.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

4.  Estimation of pressure pulse amplification between aorta and brachial artery using stepwise multiple regression models.

Authors:  F Camacho; A Avolio; N H Lovell
Journal:  Physiol Meas       Date:  2004-08       Impact factor: 2.833

5.  Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.

Authors:  Zahid Dhakam; Carmel M McEniery; John R Cockcroft; Morris J Brown; Ian B Wilkinson
Journal:  Am J Hypertens       Date:  2006-02       Impact factor: 2.689

6.  Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease).

Authors:  P C Simons; A Algra; M L Bots; D E Grobbee; Y van der Graaf
Journal:  Circulation       Date:  1999-08-31       Impact factor: 29.690

7.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  Central pulse pressure and mortality in end-stage renal disease.

Authors:  Michel E Safar; Jacques Blacher; Bruno Pannier; Alain P Guerin; Sylvain J Marchais; Pierre-Marie Guyonvarc'h; Gérard M London
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

9.  Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.

Authors:  G M London; B Pannier; A P Guerin; S J Marchais; M E Safar; J L Cuche
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

10.  Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.

Authors:  Xiong-Jing Jiang; Michael F O'Rourke; Yu-Qing Zhang; Xin-Ye He; Li-Sheng Liu
Journal:  J Hypertens       Date:  2007-05       Impact factor: 4.844

View more
  2 in total

1.  Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension.

Authors:  Radhika Soanker; M U R Naidu; Sree Bhushan Raju; A Krishna Prasad; T Ramesh Kumar Rao
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

2.  Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yi-Bang Cheng; Jia-Hui Xia; Yan Li; Ji-Guang Wang
Journal:  Front Physiol       Date:  2021-11-24       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.